From Our Readers

From Our Readers

You Make the Call

Reader Responses: Is 3 months of anticoagulation enough for a provoked VTE?

Here’s how readers responded to a You Make the Call question about the appropriate length of anticoagulation for a provoked DVT. Disclaimer: ASH does not...
You Make the Call

Reader Responses: Should a pregnant patient with hemochromatosis receive iron?

Here’s how readers responded to a You Make the Call question about the treatment of iron deficiency during pregnancy in a patient with hereditary...

The Subspecialist Will Televisit You Now

Prior to the COVID-19 pandemic, health-care providers, payers, and patients had all gradually warmed up to the opportunities for telemedicine afforded by high-speed internet...
You Make the Call

Reader Response: Is warfarin recommended for a patient with recurrent coronary artery closure?

Here’s how readers responded to a You Make the Call question about management of a patient with recurrent coronary artery closure. Disclaimer: ASH does not recommend...
You Make the Call

Reader Responses: Should this patient with DLBCL receive rituximab maintenance after R-CHOP?

Here’s how readers responded to a You Make the Call question about rituximab maintenance after R-CHOP for a patient with stage 4B diffuse large...
You Make the Call

Reader Responses: How would you treat these patients with acute stroke who are positive...

Here’s how readers responded to a You Make the Call question about anticoagulation for patients with antiphospholipid antibodies and a history of stroke. Disclaimer: ASH...
You Make the Call

Reader Responses: Would rituximab re-treatment help this patient with hemolytic anemia?

Here’s how readers responded to a You Make the Call question about treatment of Coombs-positive hemolytic anemia in a patient who declines to undergo...

The Costs of Pursuing Cancer Cures

In this edition, Jori May, MD, reviews The First Cell: And the Human Costs of Pursuing Cancer to the Last, in which hematologist-oncologist Azra...

COVID-19, Cancer, and the Need for Clarity

By Aakash Desai, MD, MPH; Gilberto Lopes Jr., MD, MBA; Nicole M. Kuderer, MD; Brian I. Rini, MD; Gary H. Lyman, MD, MPH, FRCP;...
You Make the Call

Reader Responses: How would you treat a frail patient with relapsed hairy cell leukemia variant?

Here’s how readers responded to a You Make the Call question about treatment of early-relapsing hairy cell leukemia variant. Disclaimer: ASH does not recommend or...
Advertisement

Current Issue

October 2020 Volume 6, Issue 12

This issue examines racism in the U.S. health care system, discusses the FDA's newly loosened blood donation restrictions, and more.

Block title